TaqMan mutation detection assays

Friday, 21 October, 2011 | Supplied by: Applied Biosystems Pty Ltd



TaqMan mutation detection assays detect and measure somatic mutations in genes associated with cancer.

The research-only assays are based on a technology known as competitive allele-specific PCR technology, also known as castPCR technology.

The technology is highly specific and sensitive and can detect and quantitate rare quantities of mutated DNA in a sample that contains large quantities of normal, wild-type DNA.

It is sensitive enough to detect a single mutant molecule out of 1 million normal copies, a 10-fold greater sensitivity than other mutation detection assays.

The first three assays available are designed for detecting mutations in the KRAS, BRAF and EGFR genes. However, more assays are in development for many more cancer-related genes.

Online: www.appliedbiosystems.com
Phone: 03 9730 8600
Related Products

Molecular Innovations Human Alpha-1-Antitrypsin Total Antigen ELISA Kit

Molecular Innovations' Human Alpha-1-Antitrypsin ELISA Kit is for the sensitive quantitative...

PerkinElmer LabChip Extended Range N-Linked Glycan Assay

The LabChip Extended Range N-Linked Glycan Assay enables the high-throughput sizing and...

GeneCopoeia OmicsArray protein microarrays

GeneCopoeia's OmicsArray protein microarrays are powerful tools for many applications,...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd